Dr Peter Senior
@islettx.bsky.social
Type 1 Diabetes & Clinical Islet Transplant Friendocrinologist, Director, Alberta Diabetes Institute Charles A. Allard Chair in Diabetes Research
We are delighted to welcome you to the @albertadiabetes.bsky.social institute
June 3, 2025 at 3:02 AM
We are delighted to welcome you to the @albertadiabetes.bsky.social institute
some studies use assays which are very sensitive and how much c-peptide you need to make a meaningful difference is still debated.
Probably 0.2nmol/L (= 200pmol/l or 0.6 ng/ml) is helpful
Probably 0.2nmol/L (= 200pmol/l or 0.6 ng/ml) is helpful
April 11, 2025 at 7:46 PM
some studies use assays which are very sensitive and how much c-peptide you need to make a meaningful difference is still debated.
Probably 0.2nmol/L (= 200pmol/l or 0.6 ng/ml) is helpful
Probably 0.2nmol/L (= 200pmol/l or 0.6 ng/ml) is helpful
16% of adult-onset and 6% of childhood-onset cases had residual C-peptide even >40 years from diagnosis
diabetesjournals.org/care/article...
diabetesjournals.org/care/article...
Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
OBJECTIVE. It is generally accepted that complete β-cell destruction eventually occurs in individuals with type 1 diabetes, which has implications for trea
diabetesjournals.org
April 10, 2025 at 4:24 AM
16% of adult-onset and 6% of childhood-onset cases had residual C-peptide even >40 years from diagnosis
diabetesjournals.org/care/article...
diabetesjournals.org/care/article...